Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 10, 2006. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction and does not contain financial statements or performance metrics.
Material Changes
The only material change disclosed is a transaction involving the purchase of Ordinary Shares by Mr. J Heslop on April 6, 2006. The shares were purchased under a Single Company ISA at a price of GBP 14.99 per Ordinary Share. The company and the individual were advised of this information on April 7, 2006.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to the requirements of Disclosure Rule 3.1.4R(1)(b) regarding the notification of the specific share transaction.
Key Facts for Investor Verification
- Transaction Date: April 6, 2006
- Individual Involved: Mr. J Heslop
- Transaction Type: Purchase of Ordinary Shares via Single Company ISA
- Share Price: GBP 14.99 per share
- Notification Date: April 7, 2006
- Filing Date: April 10, 2006